This trial aims to compare smaller vs. larger incisions for partial meniscus tear surgery to see if the smaller incision causes less pain & faster recovery.
4 Primary · 4 Secondary · Reporting Duration: 24 hours
2 Treatment Groups
Standard Partial Meniscectomy
1 of 2
Nanoscopic Partial Meniscectomy
1 of 2
100 Total Participants · 2 Treatment Groups
Primary Treatment: Nanoscopic Partial Meniscectomy · No Placebo Group · N/A
Who is running the clinical trial?
Age Any Age · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this research endeavor still enrolling participants?
"Affirmative. The particulars hosted on clinicaltrials.gov validate that this experiment, which was launched on December 1st 2022, is actively recruiting participants. Approximately 100 individuals are required to be enlisted from a single medical centre." - Anonymous Online Contributor
What is the recruitment rate for this clinical experiment?
"Affirmative. Records hosted on clinicaltrials.gov illustrate that this medical research study, which was initially shared December 1st 2022, is actively recruiting patients. The aim is to enlist 100 individuals from one healthcare center." - Anonymous Online Contributor
In what ways does this research endeavor seek to accomplish its goals?
"Arthrex, Inc., the sponsor of this trial, has identified Functional Outcomes following partial meniscectomy as their primary outcome to be measured on a 6-week timeline. Secondary outcomes include Visual Analog Pain Score (VAPS) from 0 to 10 in regards to postoperative pain relief; Narcotic Medication Use for quantifying narcotic pain medication taken after nanoscopic partial meniscectomy versus arthroscopy; and Return To Work time frames after receiving partial meniscectomy treatment." - Anonymous Online Contributor